Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

To Assess the Impact of Ocular Allergy Treatment on Patients Using an Opthalmic Agent (or no Treatment) Versus Alcaftadine(Lastacaft™)

NCT01808768 is registered in ClinicalTrials.gov with Starx Research Center, LLC as lead sponsor.

NCT NCT01808768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01808768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
To Assess the Impact of Ocular Allergy Treatment on Patients Using an Opthalmic Agent (or no Treatment) Versus Alcaftadine(Lastacaft™)
Lead sponsor
Starx Research Center, LLC
Phase
Phase 4
Overall status
Unknown status
Start date
April 30, 2013
Completion date
November 30, 2013
Enrollment
50 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis, rhinoconjunctivitis